Healthcare & Life Sciences
JW Therapeutics
JW Therapeutics is a Healthcare & Life Sciences startup based in China, most recent round Series B, 2 tracked investors.
Activeseries-b
series-b
Stage
2016
Founded
2
Investors
About JW Therapeutics
Based in China, JW Therapeutics is a startup founded in 2016. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
JW Therapeutics is a biotechnology company focused on developing, manufacturing, and commercializing cell immunotherapy products for hematologic malignancies, solid tumors, and autoimmune diseases.
Explore JW Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.